Tularemia market - The Biggest Trends to look out for 2017-2023
The Analysis presents the
study of Global Tularemia market facilitating the regional and country wise analysis covering the
strategic analysis of each market player and the market share they hold
The global Tularemia market is
expected to reach US$ 200 million by
2023, and the market is projected to grow at a CAGR of ~ 3.2 % during the forecast period 2017-2023.
Tularemia or rabbit fever or deer fly fever is a
rare infectious disease caused by the bacterium Francisella tularensis, which
affects skin, eyes, lymph nodes and lungs. Tularemia is transmitted from
animals such as rodents, rabbits, and hares to human. It can also affect sheep,
birds, dogs, cats, etc. The routes of acquiring infection are direct exposure
to the bacteria, airborne infections, insect bites, and bite of an infected
animal. Tularemia is highly contagious and had been used as a biological weapon
by many countries such as United States of America and Soviet Union.
Ulceroglandular tularemia is the most common form of Tularemia. Tularemia
symptoms include swollen and painful lymph glands, fever, chills, headache,
fatigue, eye swelling, pain and light sensitivity, diarrhea, pneumonia etc. If
it left untreated, it will cause serious complications such as enlarged spleen,
enlarged liver, infection around the brain and spinal cord,
irritation around the heart (pericarditis), bone infection etc. and may lead to
the death.
Top Market
Key Players: Nicholas Piramal, Alkem, Glaxo Smithkline, Bayer
AG, Ranbaxy Laboratories, Cipla Inc., Zydus Cadila, Dr. Reddy's Lab, Glenmark
Pharmaceuticals, Lupin Limited, pfizer Inc. and others.
Factors favouring the spread of Tularemia infection
are tick bites, exposure to sick or dead animals, especially, wild game. Travel
to certain regions such as Arkansas, Missouri and Oklahoma can also cause
Tularemia infection because of the concentration of ticks in those areas. Tick
bite is the leading cause for an occurrence of large number of cases.Laboratory
workers working with tularemia are at risk of airborne infection due to greater
chances of exposure to the pathogen. Tularemia infection can also be airborne
during gardening, construction or other activities, which may lead to pneumonic
tularemia. Tularemia is also contracted by eating undercooked meat of an
infected animal or drinking contaminated water. According to Centers for
Disease Control and Prevention, overall mortality of Tularemia is less than 2%
but ranges up to 24% depending on the strain.
The global Tularemia market has been segmented on
the basis of types, diagnosis, drugs, and end users.
Based on types, the market has been segmented as
the ulceroglandular tularemia, glandular tularemia, oculoglandular tularemia,
oropharyngeal tularemia, pneumonic tularemia, and others.
Based on the diagnosis, the market has been
segmented as microscopy, immunochemistry, and others.
Based on the drugs, the market has been segmented
as streptomycin, gentamicin, doxycycline, ciprofloxacin and others.
Based on the end users, the market has been
segmented as hospitals and clinics, academic and research centers, and others.
The Americas accounts for the significant market
share owing to extensive use of medications and high expenditure on the health
care. Additionally, the fastest uptake of new technology and drugs in the US
drives the global Tularemia market. However the presence and concentration of
Tularemia in the US regions, for instance, Arkansas, Missouri, Dakota,
Oklahoma, etc. are the leading cause for the dominance of US in the
global Tularemia market. Europe is the second largest market in the globe
due to a high disposable income and rising awareness about the disease.
Asia Pacific region is expected to grow rapidly and
China and India are likely to lead the market due to unmet needs during the
forecast period.
Gulf nations such as Saudi Arabia and the UAE drive
the Middle East & African market. The African region is expected to witness
a moderate growth owing to poor economic and political conditions and poor
healthcare development. However Africa is also a region of high endemic and
untreated cases of Tularemia.
Table
of Content
1.
Introduction
1.1 Definition
1.2 Scope Of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.2.2.1 Assumptions
1.2.2.2 Limitations
1.3 Market Structure
2. Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3. Market Dynamics
4. Market Factor Analysis
4.1 Porters Five Forces Model
4.2 Bargaining Power Of Suppliers
4.3 Bargaining Power Of Buyers
4.4 Threat Of New Entrants
4.5 Threat Of Substitutes
4.6 Intensity Of Rivalry
…Continued
1.1 Definition
1.2 Scope Of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.2.2.1 Assumptions
1.2.2.2 Limitations
1.3 Market Structure
2. Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3. Market Dynamics
4. Market Factor Analysis
4.1 Porters Five Forces Model
4.2 Bargaining Power Of Suppliers
4.3 Bargaining Power Of Buyers
4.4 Threat Of New Entrants
4.5 Threat Of Substitutes
4.6 Intensity Of Rivalry
…Continued
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact:
Akash Anand,
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
Comments
Post a Comment